beta-alanine has been researched along with Idiopathic Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuda, N | 1 |
| Kimura, M | 1 |
| Queliconi, BB | 1 |
| Kojima, W | 1 |
| Mishima, M | 1 |
| Takagi, K | 1 |
| Koyano, F | 1 |
| Yamano, K | 1 |
| Mizushima, T | 1 |
| Ito, Y | 1 |
| Tanaka, K | 1 |
| Ishiwari, K | 1 |
| Mingote, S | 1 |
| Correa, M | 1 |
| Trevitt, JT | 1 |
| Carlson, BB | 1 |
| Salamone, JD | 1 |
2 other studies available for beta-alanine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Parkinson's disease-related DJ-1 functions in thiol quality control against aldehyde attack in vitro.
Topics: Acetylcysteine; Aldehydes; Amino Acid Sequence; beta-Alanine; Coenzyme A; Glutathione; HeLa Cells; H | 2017 |
The GABA uptake inhibitor beta-alanine reduces pilocarpine-induced tremor and increases extracellular GABA in substantia nigra pars reticulata as measured by microdialysis.
Topics: Animals; beta-Alanine; Chromatography, High Pressure Liquid; Disease Models, Animal; Dose-Response R | 2004 |